VINC(Delisted)
Vincerx Pharma·NASDAQ
--
--(--)
VINC fundamentals
During Q4 2024, Vincerx Pharma (VINC) reported revenue of --, a YoY change of 0.00%. Net income was -7.99M, a YoY change of -61.49%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2019 | Q4,2019 | Q1,2020 | Q3,2020 | Q4,2020 | Q2,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | TTM |
|---|
Start Date | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | -- |
End Date | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Mar 31, 2020 | Jun 30, 2020 | Jun 30, 2020 | Sep 30, 2020 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Dec 31 | Jun 30 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | -- -- | 0 -- | 100 -- | 38.59K -- | 133.87K -- | 33.00K -- | 440.39K +440286.00% | 17.39M +52606.06% | 17.93M +46366.61% | 17.71M +13126.81% | 21.63M +4810.92% | 19.62M +12.82% | 16.90M -5.74% | 13.04M -26.36% | 15.41M -28.76% | 12.06M -38.55% | 9.61M -43.15% | 5.53M -57.57% | 7.48M -51.47% | 7.37M -38.92% | 7.79M -18.90% | -- -- | -- -- |
Selling, General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 33.00K -- | -- -- | 6.70M +20187.88% | 5.72M -- | 5.37M -- | 5.66M -- | 4.72M -29.47% | 4.53M -20.89% | 3.98M -25.83% | 4.50M -20.49% | 3.81M -19.29% | 3.51M -22.48% | 1.82M -54.29% | 2.92M -35.02% | 3.61M -5.22% | 3.88M +10.75% | -- -- | -- -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 10.70M -- | 12.21M -- | 12.34M -- | 15.97M -- | 13.74M +28.45% | 11.07M -9.38% | 9.06M -26.58% | 10.91M -31.68% | 8.25M -39.98% | 6.10M -44.87% | 3.71M -59.01% | 4.56M -58.24% | 3.75M -54.49% | 3.91M -35.94% | -- -- | -- -- |
Other Operating Expenses | -- -- | 0 -- | 100 -- | 38.59K -- | 133.87K -- | -- -- | 440.39K +440286.00% | -- -- | -- -- | -- -- | -- -- | 1.16M -- | 1.31M -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -- -- | 0 -- | -100 -- | -38.59K -- | -133.87K -- | -33.00K -- | -440.39K -440286.00% | -17.39M -52606.06% | -17.93M -46366.61% | -17.71M -13126.81% | -21.63M -4810.92% | -19.62M -12.82% | -16.90M +5.74% | -13.04M +26.36% | -15.41M +28.76% | -12.06M +38.55% | -9.61M +43.15% | -5.53M +57.57% | -7.48M +51.47% | -7.37M +38.92% | -7.79M +18.90% | -- -- | -- -- |
Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 27.64K -- | 26.63K -- | -- -- | 6.08K -- | 15.36M -- | -6.59M -23953.11% | 11.23M +42095.60% | 5.20M +85447.52% | 1.20M -92.17% | 22.00K +100.33% | 1.78M -84.16% | 758.00K -85.43% | 509.00K -57.65% | 602.00K +2636.36% | 583.00K -67.25% | -4.95M -753.17% | 5.56M +991.94% | -50.00K -108.31% | -- -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 15.36M -- | -6.59M -- | 11.23M -- | 5.20M -- | 1.20M -92.17% | -182.00K +97.24% | 1.32M -88.25% | 292.00K -94.39% | 182.00K -84.86% | 342.00K +287.91% | 385.00K -70.83% | -5.05M -1829.45% | 5.40M +2867.58% | -204.00K -159.65% | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -27.64K -- | -26.63K -- | -- -- | -6.08K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -204.00K -- | -460.00K -- | -466.00K -- | -327.00K -- | -260.00K -27.45% | -198.00K +56.96% | -99.00K +78.76% | -157.00K +51.99% | -154.00K +40.77% | -- -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | 27.64K -- | 26.63K -- | -- -- | 6.08K -- | -- -- | -- -- | -- -- | -- -- | -- -- | 204.00K -- | 460.00K -- | 466.00K -- | 327.00K -- | 260.00K +27.45% | 198.00K -56.96% | 99.00K -78.76% | 157.00K -51.99% | 154.00K -40.77% | -- -- | -- -- |
Pretax Income From Continuing Operations | -- -- | 0 -- | -100 -- | -10.95K -- | -107.25K -- | -33.00K -- | -434.30K -434204.00% | -2.03M -6063.64% | -24.52M -223883.93% | -6.47M -5934.72% | -16.42M -3681.68% | -18.42M -805.65% | -16.88M +31.17% | -11.26M -73.98% | -14.65M +10.80% | -11.55M +37.30% | -9.01M +46.64% | -4.95M +56.04% | -12.43M +15.16% | -1.81M +84.35% | -7.84M +12.92% | -7.99M -61.49% | -30.07M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | 512 -- | 300 -- | -- -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -- -- | 0 -- | -100 -- | -11.46K -- | -107.55K -- | -33.00K -- | -434.30K -434204.00% | -2.03M -6063.64% | -24.52M -213877.84% | -6.47M -5917.89% | -16.42M -3681.68% | -18.42M -805.65% | -16.88M +31.17% | -11.26M -73.98% | -14.65M +10.80% | -11.55M +37.30% | -9.01M +46.64% | -4.95M +56.04% | -12.43M +15.16% | -1.81M +84.35% | -7.84M +12.92% | -7.99M -61.49% | -30.07M -- |
Net Income Attributable to Owners of the Company | -- -- | 0 -- | -100 -- | -11.46K -- | -107.55K -- | -33.00K -- | -434.30K -434204.00% | -2.03M -6063.64% | -24.52M -213877.84% | -6.47M -5917.89% | -16.42M -3681.68% | -18.42M -805.65% | -16.88M +31.17% | -11.26M -73.98% | -14.65M +10.80% | -11.55M +37.30% | -9.01M +46.64% | -4.95M +56.04% | -12.43M +15.16% | -1.81M +84.35% | -7.84M +12.92% | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -- -- | 0 -- | -100 -- | -11.46K -- | -107.55K -- | -33.00K -- | -434.30K -434204.00% | -2.03M -6063.64% | -24.52M -213877.84% | -6.47M -5917.89% | -16.42M -3681.68% | -18.42M -805.65% | -16.88M +31.17% | -11.26M -73.98% | -14.65M +10.80% | -11.55M +37.30% | -9.01M +46.64% | -4.95M +56.04% | -12.43M +15.16% | -1.81M +84.35% | -7.84M +12.92% | -- -- | -- -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -19.00K -- | -2.00K -- | 15.00K -- | 10.00K -- | -67.00K -252.63% | 37.00K +1950.00% | 61.00K +306.67% | 34.00K +240.00% | -17.00K +74.63% | -44.00K -218.92% | 52.00K -14.75% | -36.00K -205.88% | 80.00K +570.59% | 15.00K +134.09% | 111.00K -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -2.03M -- | -24.54M -- | -6.47M -- | -16.41M -- | -18.41M -805.16% | -16.95M +30.95% | -11.22M -73.35% | -14.59M +11.09% | -11.52M +37.45% | -9.02M +46.75% | -4.99M +55.50% | -12.38M +15.16% | -1.84M +83.99% | -7.76M +13.97% | -7.98M -59.77% | -29.96M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -2.03M -- | -24.54M -- | -6.47M -- | -16.41M -- | -18.41M -805.16% | -16.95M +30.95% | -11.22M -73.35% | -14.59M +11.09% | -11.52M +37.45% | -9.02M +46.75% | -4.99M +55.50% | -12.38M +15.16% | -1.84M +83.99% | -7.76M +13.97% | -- -- | -- -- |
Basic EPS | 0 -- | -- -- | -- -- | 0 -- | -0.01 -- | -0.01 -- | 0 -- | -0.12 -1100.00% | -1.39 -- | -0.31 -3000.00% | -0.79 -- | -0.88 -633.33% | -0.8 +42.45% | -0.53 -70.97% | -0.69 +12.66% | -0.54 +38.64% | -0.42 +47.50% | -0.23 +56.60% | -0.58 +15.94% | -0.05 +90.74% | -0.17 +59.52% | -0.18 +21.74% | -0.98 -- |
Diluted EPS | 0 -- | -- -- | -- -- | 0 -- | -- -- | -0.01 -- | 0 -- | -0.12 -1100.00% | -1.39 -- | -- -- | -0.79 -- | -0.88 -633.33% | -0.8 +42.45% | -- -- | -0.69 +12.66% | -0.54 +38.64% | -0.42 +47.50% | -- -- | -0.58 +15.94% | -0.05 +90.74% | -0.17 +59.52% | -- -- | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
